BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15844643)

  • 1. Successful treatment of multicentric reticulohistiocytosis with a combination of infliximab, prednisolone and methotrexate.
    Lee MW; Lee EY; Jeong YI; Choi JH; Moon KC; Koh JK
    Acta Derm Venereol; 2004; 84(6):478-9. PubMed ID: 15844643
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged response of multicentric reticulohistiocytosis to low dose methotrexate.
    Rentsch JL; Martin EM; Harrison LC; Wicks IP
    J Rheumatol; 1998 May; 25(5):1012-5. PubMed ID: 9598911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of multicentric reticulohistiocytosis with adalimumab, minocycline, methotrexate.
    Yeter KC; Arkfeld DG
    Int J Rheum Dis; 2013 Feb; 16(1):105-6. PubMed ID: 23441782
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment trial of multicentric reticulohistiocytosis with a combination of predonisolone, methotrexate and alendronate.
    Satoh M; Oyama N; Yamada H; Nakamura K; Kaneko F
    J Dermatol; 2008 Mar; 35(3):168-71. PubMed ID: 18346261
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful Treatment of Multicentric Reticulohistiocytosis with Adalimumab, Prednisolone and Methotrexate.
    Motegi S; Yonemoto Y; Yanagisawa S; Toki S; Uchiyama A; Yamada K; Ishikawa O
    Acta Derm Venereol; 2016 Jan; 96(1):124-5. PubMed ID: 26072967
    [No Abstract]   [Full Text] [Related]  

  • 6. Refractory multicentric reticulohistiocytosis treated by infliximab: two cases.
    Sellam J; Deslandre CJ; Dubreuil F; Arfi S; Kahan A
    Clin Exp Rheumatol; 2005; 23(1):97-9. PubMed ID: 15789895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentric reticulohistiocytosis.
    Kaul A; Tolat SN; Belgaumkar V; Mhaske CB
    Indian J Dermatol Venereol Leprol; 2010; 76(4):404-7. PubMed ID: 20657124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate treatment of multicentric reticulohistiocytosis.
    Gourmelen O; Le Loët X; Fortier-Beaulieu M; Thomine E; Ledan G; Lauret P; Deshayes P
    J Rheumatol; 1991 Apr; 18(4):627-8. PubMed ID: 2066959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentric reticulohistiocytosis.
    Kandiah DA
    Mayo Clin Proc; 2014 Aug; 89(8):e73. PubMed ID: 25092372
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple cutaneous reticulohistiocytosis].
    Loche F; Lucas F; Bayle-Lebey P; Bazex J
    Ann Dermatol Venereol; 2000 May; 127(5):507-9. PubMed ID: 10863183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric reticulohistiocytosis successfully treated with infliximab: an illustrative case and evaluation of cytokine expression supporting anti-tumor necrosis factor therapy.
    Kalajian AH; Callen JP
    Arch Dermatol; 2008 Oct; 144(10):1360-6. PubMed ID: 18936400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of monocyte chemoattractant protein-1 in the overlying epidermis of multicentric reticulohistiocytosis lesions: a case report.
    Iwata H; Okumura Y; Seishima M; Aoyama Y
    Int J Dermatol; 2012 Apr; 51(4):492-4. PubMed ID: 22435444
    [No Abstract]   [Full Text] [Related]  

  • 13. The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
    Asano T; Suzutani K; Watanabe A; Honda A; Mori N; Yashiro M; Sato S; Kobayashi H; Watanabe H; Hazama M; Kanno T; Suzuki E; Ishii S; Migita K
    Medicine (Baltimore); 2018 Aug; 97(33):e11449. PubMed ID: 30113451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric reticulohistiocytosis - a case with minimal articular changes.
    Gajic-Veljic M; Nikolic MM; Bukilica M; Bonaci-Nikolic B
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):108-10. PubMed ID: 16405626
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicentric reticulohistiocytosis associated with Sjögren's syndrome.
    Morris-Jones R; Walker M; Hardman C
    Br J Dermatol; 2000 Sep; 143(3):649-50. PubMed ID: 10971349
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of multicentric reticulohistiocytosis with tocilizumab.
    Pacheco-Tena C; Reyes-Cordero G; Ochoa-Albíztegui R; Ríos-Barrera V; González-Chávez SA
    J Clin Rheumatol; 2013 Aug; 19(5):272-6. PubMed ID: 23872542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
    Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
    Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of multicentric reticulohistiocytosis with leflunomide.
    Lonsdale-Eccles AA; Haworth AE; McCrae FC; Young-Min SA
    Br J Dermatol; 2009 Aug; 161(2):470-2. PubMed ID: 19438863
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine as a treatment for multicentric reticulohistiocytosis.
    Chalom EC; Rosenstein ED; Kramer N
    J Rheumatol; 2000 Feb; 27(2):556. PubMed ID: 10685836
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response.
    Rinaldi F; Provenzano G; Termini A; Spinello M; La Seta F
    Ann Rheum Dis; 2005 Sep; 64(9):1375-6. PubMed ID: 16100346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.